S&P 500 Hits Record High as AI Rally Lifts Wall Street 
Trump Opens Tax-Exempt Dyed Diesel Access as Fuel Prices Surge 
Paramount Skydance Completes $110 Billion Warner Bros Discovery Deal 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
DogecoinVM Makes DOGE Transactions 300x Faster 
Anthropic Expands Claude Access for Cyber Defense Teams 
Wall Street Rises as Oil Prices Ease, Nasdaq Hits Record 
Kazakhstan and Tether Explore Tenge Stablecoin and RWA Tokenization 
German Industrial Orders Plunge 10.6% in August 
Asian Stocks Rise as Nasdaq Record Offsets Bond Yield Pressure 
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 
NASA's Artemis II Crew Arrives in Florida for Historic Moon Mission 
Indian Stocks Fall as RBI Hikes Rates to 5.50% 
Zcash Privacy Demand Rises as AI Exposes Bitcoin Transactions 
Bitmine to Stop Ethereum Buying After Reaching 5% ETH Supply 
Add as a preferred source on Google
Researchers from the Korea Advanced Institute of Science and Technology (KAIST) have developed a wearable green organic light-emitting diode (OLED) with a 470-nanometer (nm) wavelength that can cure jaundice in infants.
The OLED provides sufficient power for jaundice treatment even at low voltage, durability for over 100 hours of operation, a low operating temperature of less than 35 Celsius degrees, and flexibility that can endure over 1,000 bends at a 2 mm radius of curvature.
The bilirubin level of the infants’ serum reaches 12 milligrams per decilitre (mg/dL) within three hours of being exposed to the OLED, indicating the completed treatment of jaundice.
Unlike existing light-emitting diode (LED)-based jaundice treatment devices currently used at hospitals, the OLED showed uniform and effective treatment functions.
